| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 ABCA2 ABCA3 DHX37 YTHDC2 CHD8 ABCA7 ABCA9 DDX1 NAV2 NAV1 KIF18B DNAH9 | 2.12e-06 | 441 | 118 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | disaccharide binding | 6.92e-06 | 7 | 118 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PRUNE2 ABCA1 ABCA2 ABCA3 DHX37 YTHDC2 CHD8 ABCA7 ABCA9 DDX1 NAV2 NAV1 AGAP7P KIF18B AGAP4 DNAH9 AGAP6 | 8.78e-06 | 839 | 118 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PRUNE2 ABCA1 ABCA2 ABCA3 DHX37 YTHDC2 CHD8 ABCA7 ABCA9 DDX1 NAV2 NAV1 AGAP7P KIF18B AGAP4 DNAH9 AGAP6 | 8.91e-06 | 840 | 118 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PRUNE2 ABCA1 ABCA2 ABCA3 DHX37 YTHDC2 CHD8 ABCA7 ABCA9 DDX1 NAV2 NAV1 AGAP7P KIF18B AGAP4 DNAH9 AGAP6 | 8.91e-06 | 840 | 118 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.03e-05 | 49 | 118 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA1 ABCA2 ABCA3 DHX37 YTHDC2 CHD8 ABCA7 ABCA9 DDX1 NAV2 NAV1 AGAP7P KIF18B AGAP4 DNAH9 AGAP6 | 1.31e-05 | 775 | 118 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 ABCA2 ABCA3 DHX37 YTHDC2 CHD8 ABCA7 ABCA9 DDX1 DNAH1 NAV2 NAV1 KIF18B DNAH9 | 1.60e-05 | 614 | 118 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | galactoside binding | 1.65e-05 | 9 | 118 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.13e-05 | 28 | 118 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | apolipoprotein A-I receptor activity | 3.46e-05 | 2 | 118 | 2 | GO:0034188 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor activity | 1.03e-04 | 3 | 118 | 2 | GO:0030226 | |
| GeneOntologyMolecularFunction | floppase activity | 1.07e-04 | 16 | 118 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 2.06e-04 | 4 | 118 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 2.13e-04 | 20 | 118 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 2.13e-04 | 20 | 118 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.34e-04 | 51 | 118 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 3.42e-04 | 5 | 118 | 2 | GO:0005007 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 4.74e-04 | 109 | 118 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 5.31e-04 | 27 | 118 | 3 | GO:0004709 | |
| GeneOntologyMolecularFunction | poly(A) binding | 6.57e-04 | 29 | 118 | 3 | GO:0008143 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 9.47e-04 | 8 | 118 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 1.18e-03 | 78 | 118 | 4 | GO:0043539 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 1.21e-03 | 9 | 118 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | SNARE binding | 1.29e-03 | 136 | 118 | 5 | GO:0000149 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 1.35e-03 | 37 | 118 | 3 | GO:0070717 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.26e-03 | 93 | 118 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | helicase activity | 2.48e-03 | 158 | 118 | 5 | GO:0004386 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 6.90e-07 | 4 | 116 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 9.51e-06 | 8 | 116 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 2.80e-05 | 63 | 116 | 5 | GO:0007157 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 7.51e-05 | 15 | 116 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 7.51e-05 | 15 | 116 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | phospholipid efflux | 7.51e-05 | 15 | 116 | 3 | GO:0033700 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 1.11e-04 | 17 | 116 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 1.29e-04 | 46 | 116 | 4 | GO:0051353 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 1.33e-04 | 18 | 116 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 1.57e-04 | 19 | 116 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 1.57e-04 | 19 | 116 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 1.84e-04 | 20 | 116 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid efflux | 1.87e-04 | 4 | 116 | 2 | GO:1902994 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid efflux | 1.87e-04 | 4 | 116 | 2 | GO:1902995 | |
| GeneOntologyBiologicalProcess | alveolar secondary septum development | 1.87e-04 | 4 | 116 | 2 | GO:0061144 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 2.14e-04 | 21 | 116 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol efflux | 2.78e-04 | 56 | 116 | 4 | GO:0010874 | |
| GeneOntologyBiologicalProcess | regulation of T cell migration | 2.78e-04 | 56 | 116 | 4 | GO:2000404 | |
| GeneOntologyBiologicalProcess | sphingolipid translocation | 3.10e-04 | 5 | 116 | 2 | GO:0099039 | |
| GeneOntologyBiologicalProcess | lipid translocation | 3.63e-04 | 60 | 116 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 4.10e-04 | 26 | 116 | 3 | GO:1900424 | |
| Domain | ABC_A | 5.19e-09 | 12 | 111 | 5 | IPR026082 | |
| Domain | - | 1.55e-06 | 95 | 111 | 7 | 2.60.120.200 | |
| Domain | AAA+_ATPase | 2.32e-06 | 144 | 111 | 8 | IPR003593 | |
| Domain | AAA | 2.32e-06 | 144 | 111 | 8 | SM00382 | |
| Domain | ConA-like_dom | 6.38e-06 | 219 | 111 | 9 | IPR013320 | |
| Domain | ABC_tran | 9.46e-06 | 48 | 111 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 9.46e-06 | 48 | 111 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.05e-05 | 49 | 111 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 1.16e-05 | 50 | 111 | 5 | IPR003439 | |
| Domain | ArfGap | 2.50e-05 | 29 | 111 | 4 | SM00105 | |
| Domain | ArfGap | 2.50e-05 | 29 | 111 | 4 | PF01412 | |
| Domain | ARFGAP | 2.50e-05 | 29 | 111 | 4 | PS50115 | |
| Domain | ArfGAP | 2.50e-05 | 29 | 111 | 4 | IPR001164 | |
| Domain | Gal-bind_lectin | 8.82e-05 | 15 | 111 | 3 | PF00337 | |
| Domain | Gal-bind_lectin | 8.82e-05 | 15 | 111 | 3 | SM00908 | |
| Domain | GALECTIN | 8.82e-05 | 15 | 111 | 3 | PS51304 | |
| Domain | Galectin_CRD | 8.82e-05 | 15 | 111 | 3 | IPR001079 | |
| Domain | GLECT | 8.82e-05 | 15 | 111 | 3 | SM00276 | |
| Domain | ABC_transporter_CS | 1.11e-04 | 42 | 111 | 4 | IPR017871 | |
| Domain | FGF_rcpt_fam | 2.08e-04 | 4 | 111 | 2 | IPR016248 | |
| Domain | - | ABCA1 ABCA2 ABCA3 DHX37 YTHDC2 CHD8 ABCA7 ABCA9 DDX1 DNAH1 NAV2 NAV1 DNAH9 | 4.84e-04 | 746 | 111 | 13 | 3.40.50.300 |
| Domain | P-loop_NTPase | ABCA1 ABCA2 ABCA3 DHX37 YTHDC2 CHD8 ABCA7 ABCA9 DDX1 DNAH1 NAV2 NAV1 KIF18B DNAH9 | 4.99e-04 | 848 | 111 | 14 | IPR027417 |
| Domain | DEAH_ATP_HELICASE | 1.48e-03 | 38 | 111 | 3 | PS00690 | |
| Domain | PROTEIN_KINASE_ATP | 1.67e-03 | 459 | 111 | 9 | PS00107 | |
| Domain | Protein_kinase_ATP_BS | 1.92e-03 | 379 | 111 | 8 | IPR017441 | |
| Domain | Prot_kinase_dom | 2.56e-03 | 489 | 111 | 9 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 2.71e-03 | 493 | 111 | 9 | PS50011 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.04e-03 | 14 | 111 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.04e-03 | 14 | 111 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.04e-03 | 14 | 111 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.04e-03 | 14 | 111 | 2 | PF08393 | |
| Domain | MT | 3.04e-03 | 14 | 111 | 2 | PF12777 | |
| Domain | AAA_8 | 3.04e-03 | 14 | 111 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 3.04e-03 | 14 | 111 | 2 | IPR011704 | |
| Domain | AAA_5 | 3.04e-03 | 14 | 111 | 2 | PF07728 | |
| Domain | DHC_fam | 3.49e-03 | 15 | 111 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.49e-03 | 15 | 111 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 3.49e-03 | 15 | 111 | 2 | PF03028 | |
| Domain | Helicase_C | 3.81e-03 | 107 | 111 | 4 | PF00271 | |
| Domain | HELICc | 3.81e-03 | 107 | 111 | 4 | SM00490 | |
| Domain | ANK | 3.88e-03 | 251 | 111 | 6 | SM00248 | |
| Domain | Helicase_C | 3.94e-03 | 108 | 111 | 4 | IPR001650 | |
| Domain | ANK_REPEAT | 4.04e-03 | 253 | 111 | 6 | PS50088 | |
| Domain | HELICASE_CTER | 4.07e-03 | 109 | 111 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.07e-03 | 109 | 111 | 4 | PS51192 | |
| Domain | DEXDc | 4.07e-03 | 109 | 111 | 4 | SM00487 | |
| Domain | Ankyrin_rpt-contain_dom | 4.11e-03 | 254 | 111 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 4.11e-03 | 254 | 111 | 6 | PS50297 | |
| Domain | Helicase_ATP-bd | 4.21e-03 | 110 | 111 | 4 | IPR014001 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 4.49e-03 | 17 | 111 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 4.49e-03 | 17 | 111 | 2 | PS51059 | |
| Domain | PARP | 4.49e-03 | 17 | 111 | 2 | PF00644 | |
| Domain | DUF1605 | 4.49e-03 | 17 | 111 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 4.49e-03 | 17 | 111 | 2 | PF07717 | |
| Domain | - | 4.49e-03 | 17 | 111 | 2 | 3.90.228.10 | |
| Domain | Ankyrin_rpt | 4.78e-03 | 262 | 111 | 6 | IPR002110 | |
| Domain | Laminin_G | 4.97e-03 | 58 | 111 | 3 | IPR001791 | |
| Domain | Kinase-like_dom | 5.03e-03 | 542 | 111 | 9 | IPR011009 | |
| Domain | HA2 | 5.03e-03 | 18 | 111 | 2 | SM00847 | |
| Domain | HA2 | 5.03e-03 | 18 | 111 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 5.03e-03 | 18 | 111 | 2 | IPR007502 | |
| Domain | Ig_I-set | 5.56e-03 | 190 | 111 | 5 | IPR013098 | |
| Domain | I-set | 5.56e-03 | 190 | 111 | 5 | PF07679 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 2.16e-06 | 17 | 80 | 4 | MM14552 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 2.77e-06 | 18 | 80 | 4 | M524 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 4.74e-06 | 44 | 80 | 5 | M11911 | |
| Pubmed | 9.65e-09 | 8 | 121 | 4 | 24293640 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 19776007 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 33316546 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 9038233 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 28704475 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 4.11e-08 | 3 | 121 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 4.11e-08 | 3 | 121 | 3 | 22341088 | |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 32380082 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 23667648 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 28877989 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 19800850 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 38987795 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 37105392 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 36479526 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 4.11e-08 | 3 | 121 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 4.11e-08 | 3 | 121 | 3 | 33923930 | |
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 4.11e-08 | 3 | 121 | 3 | 31969388 | |
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 4.11e-08 | 3 | 121 | 3 | 35241678 | |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 22627368 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 33153471 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 22052881 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 4.11e-08 | 3 | 121 | 3 | 23408620 | |
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 4.11e-08 | 3 | 121 | 3 | 29458010 | |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 26582205 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 9153289 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 18974023 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 4.11e-08 | 3 | 121 | 3 | 29651447 | |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 21146220 | ||
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 4.11e-08 | 3 | 121 | 3 | 28990062 | |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 18579572 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 16990264 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 18005988 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 23585851 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 4.11e-08 | 3 | 121 | 3 | 29433546 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 4.11e-08 | 3 | 121 | 3 | 25898318 | |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 31937306 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 21426359 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 18282810 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 24083426 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 37279535 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 4.11e-08 | 3 | 121 | 3 | 25931247 | |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 17560833 | ||
| Pubmed | GAPVD1 SHROOM3 ABCA2 FBF1 TRIOBP CHD8 TUBGCP6 SULF2 SMG7 NAV2 AGAP7P AGAP4 AGAP6 | 4.43e-08 | 529 | 121 | 13 | 14621295 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 7.79e-08 | 218 | 121 | 9 | 33378226 | |
| Pubmed | 1.02e-07 | 225 | 121 | 9 | 12168954 | ||
| Pubmed | Cenpj Regulates Cilia Disassembly and Neurogenesis in the Developing Mouse Cortex. | 1.03e-07 | 33 | 121 | 5 | 30626697 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 38686388 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 22677125 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 19234217 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 35715604 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 19017954 | ||
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 1.64e-07 | 4 | 121 | 3 | 36459823 | |
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 1.64e-07 | 4 | 121 | 3 | 29611821 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 1.64e-07 | 4 | 121 | 3 | 33727589 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 25578313 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 18826117 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 38853593 | ||
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 1.64e-07 | 4 | 121 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 1.64e-07 | 4 | 121 | 3 | 18346632 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 19670381 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 1.64e-07 | 4 | 121 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 1.64e-07 | 4 | 121 | 3 | 34369876 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 33203936 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 1.64e-07 | 4 | 121 | 3 | 33963043 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 33107565 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 30763585 | ||
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 1.64e-07 | 4 | 121 | 3 | 19362679 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 29844236 | ||
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 1.64e-07 | 4 | 121 | 3 | 20463811 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 1.64e-07 | 4 | 121 | 3 | 23657851 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 24333756 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 1.64e-07 | 4 | 121 | 3 | 24958847 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 30120235 | ||
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 11839756 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 1.64e-07 | 4 | 121 | 3 | 22021615 | |
| Pubmed | CHAF1A NTAQ1 FBF1 YTHDC2 CHD8 ABCA7 PSMG3-AS1 ADCY6 TUBGCP6 CCNT1 SULF2 SMG7 USP7 ACTL6B KIF18B MGA PRRC2B | 3.45e-07 | 1116 | 121 | 17 | 31753913 | |
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 28951537 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 4.09e-07 | 5 | 121 | 3 | 34847625 | |
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 17142808 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 25158758 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 26278059 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 21385853 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 29242193 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 22469568 | ||
| Pubmed | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. | 4.09e-07 | 5 | 121 | 3 | 19782405 | |
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 4.09e-07 | 5 | 121 | 3 | 9566950 | |
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 37352334 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 33664349 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 4.09e-07 | 5 | 121 | 3 | 37884694 | |
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 28394331 | ||
| Pubmed | Tim3 binding to galectin-9 stimulates antimicrobial immunity. | 8.15e-07 | 6 | 121 | 3 | 20937702 | |
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 8674632 | ||
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 23296703 | ||
| Interaction | MAPRE3 interactions | 9.15e-06 | 230 | 119 | 9 | int:MAPRE3 | |
| Interaction | C3orf52 interactions | 1.35e-05 | 305 | 119 | 10 | int:C3orf52 | |
| GeneFamily | ATP binding cassette subfamily A | 1.58e-09 | 14 | 71 | 5 | 805 | |
| GeneFamily | ArfGAPs | 8.20e-06 | 33 | 71 | 4 | 395 | |
| GeneFamily | Galectins | 2.55e-05 | 15 | 71 | 3 | 629 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.11e-04 | 24 | 71 | 3 | 654 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.27e-04 | 161 | 71 | 5 | 593 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 5.17e-04 | 40 | 71 | 3 | 321 | |
| GeneFamily | Dyneins, axonemal | 1.99e-03 | 17 | 71 | 2 | 536 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.99e-03 | 17 | 71 | 2 | 1291 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.99e-03 | 17 | 71 | 2 | 684 | |
| GeneFamily | Ankyrin repeat domain containing | 2.62e-03 | 242 | 71 | 5 | 403 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.78e-03 | 206 | 71 | 4 | 682 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | FILIP1 EBF3 NCKAP5 PABPC5 PTPN21 ABCA9 LIFR THBS2 KIAA1217 ENAH NAV2 KIAA1755 EGFLAM FGFR3 | 1.26e-05 | 767 | 121 | 14 | M39209 |
| Coexpression | HALLMARK_BILE_ACID_METABOLISM | 1.37e-05 | 112 | 121 | 6 | M5948 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-08 | 196 | 120 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.22e-08 | 196 | 120 | 8 | 553c22c7d48f3b4f6f2b2f10d6e668c5ebb09e8c | |
| ToppCell | PBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.22e-08 | 196 | 120 | 8 | d376168e15ec1cf618723259966c76be3698b9b0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-08 | 196 | 120 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.79e-07 | 161 | 120 | 7 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.20e-07 | 171 | 120 | 7 | b113fbebb89056af0b9c775d2fb6552206a80467 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.20e-07 | 171 | 120 | 7 | 6a5ac0f56bd7b4543be103100fb735ca6bc5b8bf | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.37e-07 | 172 | 120 | 7 | f0e767a20d93e546ce278db67dbd779cc68af533 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.72e-07 | 174 | 120 | 7 | f520b79d277e286c9bb5d091e6c94e7ec7e46699 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.39e-07 | 182 | 120 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.80e-07 | 194 | 120 | 7 | 6af2971d83f5ad6aed16d0ceb8bfc52f3947bc10 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.80e-07 | 194 | 120 | 7 | 5c60670ec24470225fabaa6071fdb4ef6e579840 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 195 | 120 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 195 | 120 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | PBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.05e-06 | 196 | 120 | 7 | e1f763fa9c11bf5f4d80e79f70f9485724ac23fe | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.05e-06 | 196 | 120 | 7 | 4a9095ba3f6709f88f32bf09184553f4bd211f43 | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.20e-06 | 200 | 120 | 7 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-06 | 200 | 120 | 7 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | (51)_cDC1|World / shred on Cell_type and subtype | 1.37e-06 | 204 | 120 | 7 | a8cf4180c406674b7541917d1fc6127686ba5f8a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.16e-06 | 156 | 120 | 6 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.16e-06 | 156 | 120 | 6 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.95e-06 | 166 | 120 | 6 | bb8135119dc37fdbba476599a56d368f422688dc | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.95e-06 | 166 | 120 | 6 | 0590e404f45afce90e20f93f90a3def83949c66b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-06 | 168 | 120 | 6 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-06 | 170 | 120 | 6 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-06 | 170 | 120 | 6 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 7.05e-06 | 171 | 120 | 6 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | Club-club-15|World / Class top | 8.04e-06 | 175 | 120 | 6 | ca9d012f520f697c7450ec6958a015e20538a6a8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.31e-06 | 176 | 120 | 6 | 87de432c680b80555342afac864599bbc002c040 | |
| ToppCell | COPD-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 9.75e-06 | 181 | 120 | 6 | 675603a401d92cf9fdcd44e211ec899fa86a0d49 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 182 | 120 | 6 | f231e86524b628e6e11ac33d5c34be99d454a92a | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 1.04e-05 | 183 | 120 | 6 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 183 | 120 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 1.04e-05 | 183 | 120 | 6 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-05 | 185 | 120 | 6 | 57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 185 | 120 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | (3)_DC_1|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.21e-05 | 188 | 120 | 6 | ee616d14e060385ee55e4cd5b60218e9374c6065 | |
| ToppCell | COPD-Myeloid-DC_Mature|COPD / Disease state, Lineage and Cell class | 1.21e-05 | 188 | 120 | 6 | de93ccb53edb8599da9e312db0e3af604c21f673 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 188 | 120 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.21e-05 | 188 | 120 | 6 | 5e5d779ea079d3b2a1ef650b06b9f5cc1ffef5e7 | |
| ToppCell | IPF-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 1.25e-05 | 189 | 120 | 6 | 49e67d298d045f29136919b7d9971b6502b0efaa | |
| ToppCell | (3)_DC_activated|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.25e-05 | 189 | 120 | 6 | e977838793fc0eb1499e81018e33e4ccb4a5f0c5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 190 | 120 | 6 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 190 | 120 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 190 | 120 | 6 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 190 | 120 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.32e-05 | 191 | 120 | 6 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 191 | 120 | 6 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 191 | 120 | 6 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 191 | 120 | 6 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 191 | 120 | 6 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 192 | 120 | 6 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | COPD-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 1.36e-05 | 192 | 120 | 6 | baebd462f464e7d0e462d07a74bb5d685a9fc3b6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-05 | 192 | 120 | 6 | d0fb6885f023d55a2b7984c99db9c6463258f788 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-05 | 193 | 120 | 6 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 193 | 120 | 6 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.40e-05 | 193 | 120 | 6 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 194 | 120 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-05 | 194 | 120 | 6 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.44e-05 | 194 | 120 | 6 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 194 | 120 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 194 | 120 | 6 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 194 | 120 | 6 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 194 | 120 | 6 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 194 | 120 | 6 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 194 | 120 | 6 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 194 | 120 | 6 | c45e9d09b5cd6973de6c3f1713b3bf36fa4bfe57 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 194 | 120 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-05 | 195 | 120 | 6 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 195 | 120 | 6 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.53e-05 | 196 | 120 | 6 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.53e-05 | 196 | 120 | 6 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 196 | 120 | 6 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | Control-Myeloid-cDC|Control / Disease group, lineage and cell class | 1.53e-05 | 196 | 120 | 6 | 85d92bc226cc28384c30991cc4ebb02ec2e3ec99 | |
| ToppCell | healthy_donor-Myeloid-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.53e-05 | 196 | 120 | 6 | ea590b8ea3d13ff93cb5863a44936b0cfdf3b868 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-05 | 196 | 120 | 6 | bbdc92ec2e95ed7d782df0c72d94f9a9d9439bf0 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.53e-05 | 196 | 120 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | healthy_donor-Myeloid-Dendritic-cDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.53e-05 | 196 | 120 | 6 | aac79fc45cab4a16e2fa02652ece0999591261a5 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.53e-05 | 196 | 120 | 6 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.58e-05 | 197 | 120 | 6 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.58e-05 | 197 | 120 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | Healthy_donor-cDC|Healthy_donor / disease group, cell group and cell class (v2) | 1.58e-05 | 197 | 120 | 6 | b57a27e5b855bbdd1dfa352540599d260dc482aa | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.58e-05 | 197 | 120 | 6 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Healthy/Control-cDC|World / Disease group and Cell class | 1.58e-05 | 197 | 120 | 6 | 4497d4073f4d3e74de907325fba9eb4af5766bf4 | |
| ToppCell | Healthy/Control-cDC|Healthy/Control / Disease group and Cell class | 1.58e-05 | 197 | 120 | 6 | 926423aae9fcf654f84b0f7621103a6a22d3aced | |
| ToppCell | Healthy_donor-cDC|World / disease group, cell group and cell class (v2) | 1.58e-05 | 197 | 120 | 6 | a545fe3a80cd721bf01115bbb645753840ec9f40 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-05 | 198 | 120 | 6 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.67e-05 | 199 | 120 | 6 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | Caecum-(5)_Dendritic_cell-(51)_cDC1|Caecum / shred on region, Cell_type, and subtype | 1.67e-05 | 199 | 120 | 6 | 2b97fda45241b2ce7be904cf081cabcf3eb5ba1d | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.67e-05 | 199 | 120 | 6 | 6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe | |
| ToppCell | (5)_Dendritic_cell|World / shred on Cell_type and subtype | 1.67e-05 | 199 | 120 | 6 | 495de74a918c5c625a2d0ef120fe4162d4ce6e76 | |
| ToppCell | Caecum-Dendritic_cell-cDC1|Caecum / Region, Cell class and subclass | 1.67e-05 | 199 | 120 | 6 | 9ab38a0060a883de6fe3da8cdac42e124d7981d9 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Caecum-Dendritic_cell|Caecum / Region, Cell class and subclass | 1.72e-05 | 200 | 120 | 6 | b91d3d7505a022ca360ab5b3f9955753d111f974 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Control-Control-Myeloid-cDC|Control / Disease, condition lineage and cell class | 1.72e-05 | 200 | 120 | 6 | 1375d199320feb85ba06e74b10df6521e790addf | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-cDC|COVID-19_Severe / Disease, condition lineage and cell class | 1.72e-05 | 200 | 120 | 6 | e7b808d8ed65343a4345fafb03015fe4f7ce302f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 200 | 120 | 6 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Caecum-(5)_Dendritic_cell|Caecum / shred on region, Cell_type, and subtype | 1.72e-05 | 200 | 120 | 6 | aa87810706fd4164085d8e973359b68a2691842e | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Cdc20)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.82e-05 | 131 | 120 | 5 | f9fb8d74ca720b81fd5910cc975510359a8ef751 | |
| Disease | cerebral palsy (implicated_via_orthology) | 6.78e-06 | 10 | 115 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ABCA1 ABCA3 ELOA2 FOLH1 F5 ABCA9 LIFR CFAP77 MKI67 FGFR3 PLPPR2 CUX1 | 1.98e-05 | 702 | 115 | 12 | C0009402 |
| Disease | bone disease (implicated_via_orthology) | 1.49e-04 | 5 | 115 | 2 | DOID:0080001 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | FILIP1 SHROOM3 CHAF1A MAP3K14 TRIOBP NCKAP5 RETSAT SULF2 NAV2 NAV1 KIAA1755 ACTL6B FGFR3 MAP3K7 CUX1 | 2.34e-04 | 1345 | 115 | 15 | EFO_0010736 |
| Disease | arteriosclerosis (implicated_via_orthology) | 3.12e-04 | 7 | 115 | 2 | DOID:2349 (implicated_via_orthology) | |
| Disease | xerostomia | 4.15e-04 | 8 | 115 | 2 | EFO_0009869 | |
| Disease | venous thromboembolism, response to antineoplastic agent | 5.52e-04 | 41 | 115 | 3 | EFO_0004286, GO_0097327 | |
| Disease | uric acid measurement | 6.56e-04 | 610 | 115 | 9 | EFO_0004761 | |
| Disease | high grade glioma (implicated_via_orthology) | 6.80e-04 | 44 | 115 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | lip morphology measurement | 8.88e-04 | 189 | 115 | 5 | EFO_0007845 | |
| Disease | urinary nitrogen measurement | 1.33e-03 | 14 | 115 | 2 | EFO_0005190 | |
| Disease | cortical thickness | SHROOM3 CHAF1A TRIOBP NCKAP5 SPECC1 SULF2 SMG7 NAV2 NAV1 KIAA1755 FGFR3 MAP3K7 | 1.36e-03 | 1113 | 115 | 12 | EFO_0004840 |
| Disease | urate measurement, spine bone mineral density | 1.52e-03 | 58 | 115 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Situs ambiguus | 1.53e-03 | 15 | 115 | 2 | C0266642 | |
| Disease | creatinine measurement | GAPVD1 SHROOM3 SPEG MAP3K14 GATM DDX1 CEP89 KCNQ1 KIAA1755 FGFR4 CUX1 | 1.78e-03 | 995 | 115 | 11 | EFO_0004518 |
| Disease | chronic kidney disease | 2.32e-03 | 235 | 115 | 5 | EFO_0003884 | |
| Disease | serum homoarginine measurement | 2.73e-03 | 20 | 115 | 2 | EFO_0005421 | |
| Disease | kidney disease (biomarker_via_orthology) | 3.01e-03 | 21 | 115 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 3.01e-03 | 21 | 115 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | atrial fibrillation | 3.39e-03 | 371 | 115 | 6 | EFO_0000275 | |
| Disease | erythrocyte measurement | 3.40e-03 | 257 | 115 | 5 | EFO_0005047 | |
| Disease | Disproportionate short stature | 3.42e-03 | 77 | 115 | 3 | C0878659 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TPTPVCKRSMRWSNL | 216 | Q96P64 | |
| WSGSNMKSPPVERSH | 451 | Q9Y6R9 | |
| VLSGKWPSSRRSQEM | 2171 | Q9HCK8 | |
| LLLWRGDSPMRPNSD | 876 | Q63HQ2 | |
| MPEARSSGPDLTRWR | 1 | Q6ZQR2 | |
| GTRPGMASTKLSPWD | 846 | Q6QNK2 | |
| MPRWVPDRAFSRTKD | 581 | O43306 | |
| GSVSDMLSRPKPWSK | 976 | P39880 | |
| SAPFLKGRTIMGWPD | 96 | Q8IUA7 | |
| PVLMSEAPWNTRAKR | 116 | O94805 | |
| KWSMERLQAPPRPET | 296 | P39086 | |
| TSNGRLPVKWMAPEA | 646 | P22455 | |
| PTTGMDPKARRFLWN | 2071 | O95477 | |
| MVAERSPARSPGSWL | 1 | P58335 | |
| MRSAAKPWNPAIRAG | 1 | Q5M775 | |
| PSTGMDPVARRLLWD | 1541 | Q99758 | |
| SSRKGRQRSMVWPGD | 606 | Q14161 | |
| VEMLPGKRWLSSQPS | 326 | O60563 | |
| TSGPRMCPRKEQDSW | 211 | Q13111 | |
| EPTTGMDPSARRFLW | 1951 | Q8IZY2 | |
| TPTPVCKRSMRWSNL | 216 | Q5VW22 | |
| ETPRSSGSMRNRWKP | 176 | Q99618 | |
| QSMASRDARCPEWKP | 71 | Q2M243 | |
| PDTWRNRKLMAPVNG | 56 | Q8NFF2 | |
| RGPTPRTEEAAWAAM | 301 | Q8NBR0 | |
| LSMPSGPSGKRWSKD | 1036 | Q4ADV7 | |
| ALGRQPSSALSWMPE | 636 | O60393 | |
| QDGMPGRSWASKRVS | 66 | Q9UGN5 | |
| MWSQRDPSLRKSGVG | 76 | Q5JQF8 | |
| LAQAMWTLPGTRPER | 296 | Q5TGI0 | |
| ETPRMPSWASARDRQ | 261 | Q8IYF1 | |
| WSRINPNKARIPMAG | 266 | Q460N3 | |
| MAAASSPPRAERKRW | 1 | P51787 | |
| PPDWRLESSNGKMAS | 346 | Q9NQ29 | |
| SWILSPSSMSEPRRG | 126 | Q96PY0 | |
| SNSTDTLWRPMPKLA | 2976 | Q8IWI9 | |
| RGAKWTTAPKPTMAD | 206 | P50440 | |
| SKGRWDQPPLDSLGM | 1086 | Q5JYT7 | |
| NSWGSEERSLPRKMP | 286 | Q6DKI2 | |
| NSWGSEERSLPRKMP | 286 | Q3B8N2 | |
| SWGSEERSLPRKMPF | 286 | O00182 | |
| LEKMGGSAPPDSSWR | 306 | Q04609 | |
| VSSVRRPMSDPSWNR | 906 | Q14C86 | |
| RPMSDPSWNRRPGNE | 911 | Q14C86 | |
| GPDRWESLSKGQRMQ | 871 | Q15751 | |
| AKDNTRPGANSPEMW | 471 | Q92499 | |
| RPGANSPEMWSEAIK | 476 | Q92499 | |
| MADQLRKPPSRDQWS | 586 | P0DPD6 | |
| ERGRGNLEWKEPPSM | 191 | P55899 | |
| KLPPGWEKRMSRSSG | 6 | Q13526 | |
| SPNRSTNTLKEMPWG | 641 | Q8IXT1 | |
| SLMTRCWSKDPSQRP | 261 | O43318 | |
| LGESVSDMAPARPRW | 1171 | Q96RT7 | |
| GTGMERWPRTPKEEA | 2056 | P46013 | |
| TPAQGSRWPMEKKRR | 616 | Q86Y91 | |
| SSRMLQPSSSPLWGK | 231 | Q9Y3T9 | |
| PRKSPVGMLDLSSWS | 2211 | O95613 | |
| PSAGLRSDPSIMNWE | 1021 | Q86Y13 | |
| GNPIPERRWIKNSAM | 916 | Q96RW7 | |
| AEAQRPWRDGLLMPS | 781 | Q16825 | |
| RRLSPWEDLGQAPTM | 296 | Q96GM1 | |
| GKPFRLMWSQPDDRL | 86 | Q96DU9 | |
| LSMGGTWASKEPLRP | 11 | Q6NT52 | |
| SREAPPWENSSMRGL | 716 | O14976 | |
| QWALSTPRMRKGPSV | 416 | Q9P2D7 | |
| TRPSKALWPAQMSAA | 76 | Q8N8I6 | |
| MASSPIQPRKGGADW | 331 | Q8TES7 | |
| GRVEMRKWSSEPGPE | 136 | Q9NVR0 | |
| KARPSMGDWRPRSVD | 166 | Q5SW24 | |
| TSQLRPRPNWQSEMG | 96 | Q96ST8 | |
| PRPNWQSEMGRRSSL | 101 | Q96ST8 | |
| EPSRTWARGRMDTQP | 626 | Q99501 | |
| WARGRMDTQPDRKPS | 631 | Q99501 | |
| IDGCSPIKNWSPMRL | 321 | Q6PGQ7 | |
| EPTTGMDPKARRFLW | 2211 | Q9BZC7 | |
| TPTPVCKRSMRWSNL | 216 | Q5VUJ5 | |
| EPTRKPWERTNTMNG | 491 | Q8N8S7 | |
| MAPRGRVPKDRSWKA | 3196 | Q9NYC9 | |
| TTNGRLPVKWMAPEA | 651 | P22607 | |
| KEEPLGSGMNPVRSW | 16 | Q9H4W6 | |
| WLERGRLAMLTPNSP | 766 | P82279 | |
| RNLFRPSLPSSWKEM | 416 | O95479 | |
| SSPGTMLKTWARLQP | 1086 | Q8IY37 | |
| LKSMWPLPSATQRRA | 116 | A6NEL3 | |
| WRGSTPKEMGRETTK | 1006 | Q56UN5 | |
| RSHMKDSSGNWREPP | 146 | Q96HA8 | |
| RSEPCLMDWRKVPSN | 666 | P42702 | |
| MEPGSKSVSRSDWQP | 1 | Q05469 | |
| SWNMVLARGRPTDTP | 841 | Q99558 | |
| GSLSPPWDQDRRMMF | 1201 | Q96PC5 | |
| LKMEPGTSKWRRERP | 491 | Q8NEY1 | |
| KDPTWEDRFPGRSTM | 446 | Q6NUM9 | |
| RPSFTRTWSGDKGPM | 21 | Q8IZ73 | |
| WSPAEDKKPLTRMTG | 356 | Q9NVX2 | |
| NPTWRSLDFGIMPDR | 91 | Q9P2Y5 | |
| EKWSTSRPGMGLRRN | 451 | Q7Z5M5 | |
| PSVRDPNEWAMAKSG | 826 | Q8WUY3 | |
| QTPPWLMASRSSDKD | 56 | Q9BSW7 | |
| PSQDTGSPSRMRPWK | 911 | P12259 | |
| PWMRKRENGPSITQE | 871 | Q7Z7B0 | |
| SRMPSRRDWVQCPKS | 876 | O14513 | |
| RTADRWKTDKPAMGG | 1041 | Q92540 | |
| SGIKMEPGSKWRRNP | 1021 | Q8IVL1 | |
| RKWMRENVPENSRPA | 46 | O75368 | |
| GRDRLGPLKMSDSTW | 201 | Q8NE22 | |
| RPSDPPKWERGMENS | 1211 | Q5T5P2 | |
| PREPSSWGARAGKSM | 1206 | Q8TF72 | |
| MESSRWDKDPPGERR | 1 | Q8N8Z3 | |
| PLKGRLVTSWRMPGD | 1741 | Q9H2D6 | |
| EVRMRRWSKTASPPV | 71 | Q8TAT8 | |
| PFPGTIKSRDMSWKR | 101 | P49842 | |
| LGPWVMAARSKDAAP | 16 | Q53GI3 | |
| GRMVTLTWNPPRSLD | 1296 | Q15772 | |
| LMQLCWSSEPKDRPS | 261 | Q9Y572 | |
| PSKMRTWVQSQGPRS | 91 | Q8NBB4 | |
| RIMLNCWSGDPKARP | 1146 | P35916 | |
| SGNFLPPSWRKLMSD | 606 | Q9H0D6 | |
| PPSWRKLMSDPDSSI | 611 | Q9H0D6 | |
| RESSDVPPMKRNNWI | 1036 | Q5JSZ5 | |
| KQWMPPRSNRFTAEE | 406 | A8MT19 | |
| SPQMQSAPKRWREEL | 101 | Q9BQI6 | |
| RRMRAPSKPWSQVDE | 1136 | Q9H6S0 | |
| PPKTRNMSACWQDGR | 311 | P35442 | |
| WTVGTSPTQEKRMLP | 121 | Q5QJ38 | |
| RLWPMQARSNGTKRP | 621 | Q93009 | |
| GVKLAKTPMRTWGPR | 286 | Q9H091 | |
| PEMKRPSSKSLGQLW | 851 | Q8IWU5 | |
| WKSMPRLPTDLDIGG | 451 | P35125 |